PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
25-Jun-2020 Stevanato Group Signs an Agreement With the Coalition for Epidemic Preparedness Innovations (CEPI) to Provide Pharma Glass Vials for 2 Billion Doses of COVID-19 Vaccines Under Development Stevanato Group
25-Jun-2020 Stevanato Group Signs an Agreement With the Coalition for Epidemic Preparedness Innovations (CEPI) to Provide Pharma Glass Vials for 2 Billion Doses of COVID-19 Vaccines Under Development Stevanato Group
25-Jun-2020 Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies B3C newswire
25-Jun-2020 Moberg Pharma Meets Primary Endpoint in the European Phase 3 Study Moberg Pharma
24-Jun-2020 Positive Results from Phase 2 WILLOW Study of Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis Presented at ATS Virtual Clinical Trials Session Insmed Incorporated
24-Jun-2020 Bayer Aktiengesellschaft: Bayer announces agreements to resolve major legacy Monsanto litigation Bayer Aktiengesellschaft
24-Jun-2020 MagForce AG enters into an Agreement with Yorkville Advisors Global LP to issue Convertible Bonds in the amount of up to EUR 15 million MagForce AG
24-Jun-2020 Heidelberg Pharma to Present at the Upcoming Virtual European Biotech Investor Day 2020 Heidelberg Pharma AG
24-Jun-2020 Annual General Meeting of Gerresheimer AG Approves Dividend Increase to EUR 1.20 per Share Gerresheimer AG
24-Jun-2020 EVOTEC, SAMSARA BIOCAPITAL, AND KCK LAUNCH AUTOBAHN LABS Evotec SE
24-Jun-2020 Soligenix Completes Enrollment in its Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis Soligenix, Inc.
24-Jun-2020 Alkermes Awards COVID-19 Relief Fund Grants to 10 Innovative Programs Designed to Address Challenges for Patient Communities Alkermes plc
24-Jun-2020 Samsara BioCapital, Evotec and KCK Launch Autobahn Labs, a Novel Early Stage Drug Discovery Incubator Autobahn Labs
24-Jun-2020 BrainStorm Expands Clinical Pipeline to Evaluate NurOwn® for the Treatment of Alzheimer's Disease Brainstorm Cell Therapeutics Inc
24-Jun-2020 Biohaven Announces Obsessive-Compulsive Disorder (OCD) Proof Of Concept Phase 2/3 Study Results And Program Update Biohaven Pharmaceutical Holding Company Ltd.
24-Jun-2020 BioGeneration Ventures Closes BGV IV Fund at €105 Million B3C newswire
24-Jun-2020 Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP in the US Mayne Pharma
24-Jun-2020 InxMed Released Research Data of "FAK inhibitor IN10018 overcomes drug resistance of KRAS G12C inhibition" at 2020 AACR Annual Meeting InxMed
23-Jun-2020 FDA Announces First of Its Kind Pilot Program to Communicate Patient Reported Outcomes from Cancer Clinical Trials U.S. Food and Drug Administration
23-Jun-2020 IgNova Files Patent Application on Antibody Against COVID-19 IgNova GmbH